Literature DB >> 29061061

Metabolic disturbances induce malignant heart arrhythmias in rats.

B Liptak, V Knezl, Z Gasparova.   

Abstract

OBJECTIVES: Metabolic disturbances are considered to condition the occurrence of malignant heart arrhythmias and negatively influence the chances of a patient to survive. To test this assumption, a model of metabolic syndrome was selected in which rats were receiving a diet resembling that of the westernized population.
BACKGROUND: Metabolic syndrome is a comorbidity of major cardiovascular risk factors (dyslipidemia, hypertension, impaired glucose tolerance or insulin resistance, diabetes mellitus, and obesity), all facilitating cardiovascular complications leading to morbidity and mortality of patients.
METHODS: Hearts were isolated and perfused according to Langendorff. Global ischemia was induced in the hearts and arrhythmia occurrence in reperfusion was monitored. All hearts were stimulated with the electro-cardio-stimulator to test the electrical inducibility of heart arrhythmia.
RESULTS: Isolated hearts from rats with the metabolic syndrome were more susceptible to ventricular arrhythmias. The high-fat diet increased the occurrence of malignant heart arrhythmias in rats with metabolic syndrome to an even greater extent. All subjects with metabolic syndrome were sensitive to ventricular tachyarrhythmia with significantly decreased threshold to its induction in cardio-stimulation.
CONCLUSIONS: These results indicate that metabolic syndrome patients may be more sensitive to the occurrence of malignant heart arrhythmias following myocardial infarction or other heart diseases (Tab. 1, Fig. 2, Ref. 34).

Entities:  

Keywords:  Langendorff; dyslipidemia; ischemia-reperfusion; ventricular fibrillation western-diet.

Mesh:

Year:  2017        PMID: 29061061     DOI: 10.4149/BLL_2017_103

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  3 in total

1.  Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects.

Authors:  Vladimír Knezl; Ružena Sotníková; Zuzana Brnoliaková; Tatiana Stankovičová; Viktor Bauer; Štefan Bezek
Journal:  Interdiscip Toxicol       Date:  2018-02-14

Review 2.  Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum.

Authors:  Iokfai Cheang; Shengen Liao; Qingqing Zhu; Gehui Ni; Cong Wei; Zhenhua Jia; Yiling Wu; Xinli Li
Journal:  Front Pharmacol       Date:  2022-03-15       Impact factor: 5.810

3.  Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling.

Authors:  Hong-Jie Yang; Bin Kong; Wei Shuai; Jing-Jing Zhang; He Huang
Journal:  Front Pharmacol       Date:  2020-07-09       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.